From their early successes in medicine, organometallic compounds continue to attract interest as potential chemotherapeutics to treat a range of diseases. Here, we show from recent literature selected largely from the last two years that organometallics offer unique opportunities in medicine and, increasingly, a mechanistic-based approach is applied to their development, which has not always been the case.
Keywords: Bioinorganic chemistry; Bioorganometallic chemistry; Chemotherapy; Metallodrugs.
Copyright © 2019 Elsevier Ltd. All rights reserved.